A Multiplex HRMS Assay for Quantifying Selected Human Plasma Bile Acids as Candidate OATP Biomarkers

References

• Rodrigues AD , TaskarKS, KusuharaH, SugiyamaY. Endogenous probes for drug transporters: balancing vision with reality. Clin. Pharmacol. Ther.103 (3), 434–448 (2017).
   PubMed Web of Science ®Google Scholar
• Fowler S , MorcosPN, ClearyYet al. Progress in prediction and interpretation of clinically relevant metabolic drug-drug interactions: a minireview illustrating recent developments and current opportunities. Curr. Pharmacol. Rep.3 (1), 36–49 (2017).
   PubMedGoogle Scholar
• Kumar S , SharmaR, RoychowdhuryA. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective. Curr. Med. Chem.19 (21), 3605–3621 (2012).
   PubMed Web of Science ®Google Scholar
• Sohlenius-Sternbeck AK , MeyersonG, HagbjorkAL, JuricS, TereliusY. A strategy for early-risk predictions of clinical drug-drug interactions involving the GastroPlusTM DDI module for time-dependent CYP inhibitors. Xenobiotica48 (4), 348–356 (2017).
   PubMed Web of Science ®Google Scholar
• Vaidyanathan J , YoshidaK, AryaV, ZhangL. Comparing various in vitro prediction criteria to assess the potential of a new molecular entity to inhibit organic anion transporting polypeptide 1B1. J. Clin. Pharmacol.56 (Suppl. 7), S59–S72 (2016).
   PubMedGoogle Scholar
• Yoshida K , ZhaoP, ZhangLet al. In vitro–in vivo extrapolation of metabolism- and transporter-mediated drug–drug interactions-overview of basic prediction methods. J. Pharm. Sci.106 (9), 2209–2213 (2017).
   PubMed Web of Science ®Google Scholar
• Bednarczyk D , BoiselleC. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. Xenobiotica46 (5), 457–466 (2016).
   PubMed Web of Science ®Google Scholar
• Hayashi Y , UdagawaM. High-pressure liquid chromatography combined with fluorescence detection and solvent extraction for simultaneous determination of coproporphyrins I and III in human urine. Talanta30 (5), 368–370 (1983).
   PubMed Web of Science ®Google Scholar
• Sakai T , NiinumaY, YanagiharaS, UshioK. Liquid-chromatographic separation and determination of coproporphyrins I and III in urine. Clin. Chem.29 (2), 350–353 (1983).
   PubMed Web of Science ®Google Scholar
• Shen H , ChenW, DrexlerDMet al. Comparative evaluation of plasma bile acids, dehydroepiandrosterone sulfate, hexadecanedioate, and tetradecanedioate with coproporphyrins I and III as markers of OATP inhibition in healthy subjects. Drug Metab. Dispos.45 (8), 908–919 (2017).
   PubMed Web of Science ®Google Scholar
• Shen H , DaiJ, LiuTet al. Coproporphyrins I and III as functional markers of OATP1B activity: in vitro and in vivo evaluation in preclinical species. J. Pharmacol. Exp. Ther.357 (2), 382–393 (2016).
   PubMed Web of Science ®Google Scholar
• Lai Y , MandlekarS, ShenHet al. Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition. J. Pharmacol. Exp. Ther.358 (3), 397–404 (2016).
   PubMed Web of Science ®Google Scholar
• Minato K , SuzukiM, NagaoH, SuzukiR, OchiaiH. Development of analytical method for simultaneous determination of five rodent unique bile acids in rat plasma using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.1002, 399–410 (2015).
   PubMed Web of Science ®Google Scholar
• Ito S , KusuharaH, KumagaiYet al. N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K). Clin. Pharmacol. Ther.92 (5), 635–641 (2012).
   PubMed Web of Science ®Google Scholar
• Lechner C , IshiguroN, FukuharaAet al. Impact of experimental conditions on the evaluation of interactions between multidrug and toxin extrusion proteins and candidate drugs. Drug Metab. Dispos.44 (8), 1381–1389 (2016).
   PubMed Web of Science ®Google Scholar
• Bathena SP , MukherjeeS, OliveraM, AlnoutiY. The profile of bile acids and their sulfate metabolites in human urine and serum. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.942–943, 53–62 (2013).
   PubMed Web of Science ®Google Scholar
• Thakare R , GaoH, KosaREet al. Leveraging of rifampicin-dosed cynomolgus monkeys to identify bile acid 3-O-sulfate conjugates as potential novel biomarkers for organic anion-transporting polypeptides. Drug Metab. Dispos.45 (7), 721–733 (2017).
   PubMed Web of Science ®Google Scholar
• Balkman CE , CenterSA, RandolphJFet al. Evaluation of urine sulfated and nonsulfated bile acids as a diagnostic test for liver disease in dogs. J. Am. Vet. Med. Assoc.222 (10), 1368–1375 (2003).
   PubMed Web of Science ®Google Scholar
• Batta AK , SalenG. Gas chromatography of bile acids. J. Chromatogr. B Biomed. Sci. Appl.723 (1–2), 1–16 (1999).
   PubMed Web of Science ®Google Scholar
• Gatti R , RodaA, CerreC, BonazziD, CavriniV. HPLC-fluorescence determination of individual free and conjugated bile acids in human serum. Biomed. Chromatogr.11 (1), 11–15 (1997).
   PubMed Web of Science ®Google Scholar
• Tadano T , KanohM, MatsumotoM, SakamotoK, KamanoT. Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry. Rinsho Byori54 (2), 103–110 (2006).
   PubMedGoogle Scholar
• Nittono H , ObinataK, NakatsuNet al. Sulfated and nonsulfated bile acids in urine of patients with biliary atresia: analysis of bile acids by high-performance liquid chromatography. J. Pediatr. Gastroenterol. Nutr.5 (1), 23–29 (1986).
   PubMed Web of Science ®Google Scholar
• Luo L , SchomakerS, HouleC, AubrechtJ, ColangeloJL. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents. Toxicol. Sci.137 (1), 12–25 (2014).
   PubMed Web of Science ®Google Scholar
• Xiang X , HanY, NeuvonenM, LaitilaJ, NeuvonenPJ, NiemiM. High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.878 (1), 51–60 (2010).
   PubMed Web of Science ®Google Scholar
• Yang T , ShuT, LiuGet al. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids. J. Steroid Biochem. Mol. Biol.172, 69–78 (2017).
   PubMed Web of Science ®Google Scholar
• Meng M . Liquid chromatography-high-resolution mass spectrometry for regulated bioanalysis: bile acid and oligonucleotide quantitation as a reference. Bioanalysis8 (24), 2519–2521 (2016).
   PubMed Web of Science ®Google Scholar
• Voelker T , WangH, IrishMet al. Method development and validation of six bile acids for regulated bioanalysis: improving selectivity and sensitivity. Bioanalysis5 (10), 1229–1248 (2013).
   PubMed Web of Science ®Google Scholar
• Ding J , LundET, ZulkoskiJ, LindsayJP, McKenzieDL. High-throughput bioanalysis of bile acids and their conjugates using UHPLC coupled to HRMS. Bioanalysis5 (20), 2481–2494 (2013).
   PubMed Web of Science ®Google Scholar
• Sarafian MH , LewisMR, PechlivanisAet al. Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry. Anal. Chem.87 (19), 9662–9670 (2015).
   PubMed Web of Science ®Google Scholar
• Rago B , NegahbanA. Outsource-ability of high-resolution MS-based DMPK assays. Bioanalysis8 (16), 1641–1644 (2016).
   PubMed Web of Science ®Google Scholar
• Garofolo W , SavoieN. The decennial index of the White Papers in bioanalysis: ‘a decade of recommendations (2007–2016)’. Bioanalysis9 (21), 1681–1702 (2017).
   PubMed Web of Science ®Google Scholar
• Ramanathan R , JosephsJL, JemalM, ArnoldM, HumphreysWG. Novel MS solutions inspired by MIST. Bioanalysis2 (7), 1291–1313 (2010).
   PubMed Web of Science ®Google Scholar
• Jones BR , SchultzGA, EcksteinJA, AckermannBL. Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules. Bioanalysis4 (19), 2343–2356 (2012).
   PubMed Web of Science ®Google Scholar
• Thakare R , ChhonkerYS, GautamN, AlamoudiJA, AlnoutiY. Quantitative analysis of endogenous compounds. J. Pharm. Biomed. Anal.128, 426–437 (2016).
   PubMed Web of Science ®Google Scholar